FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Interdisziplinäres Zentrum für Klinische Forschung (IZKF)
Friedrich-Alexander-Universität Erlangen-Nürnberg
Friedrich-Alexander-Universität Erlangen-Nürnberg Zentralbereich
Interdisziplinäre Zentren
Overview
Publications
(597)
Research Grants
(257)
Research Fields
(5)
Project Types
Toggle all
Third Party Funds Group - Overall project
Third Party Funds Group - Overall project
Third Party Funds Group - Sub project
Third Party Funds Group - Sub project
Third party funded individual grant
Third party funded individual grant
Internally funded project
Internally funded project
FAU own research funding: EFI / IZKF / EAM ...
FAU own research funding: EFI / IZKF / EAM ...
Non-FAU Project
Non-FAU Project
Status
All
Upcoming
Ongoing
Finished
Project year
From
To
Filters (inactive)
P059: Regional inflammatory susceptibility of the central nervous system in rheumatoid arthritis
March 1, 2020 - Nov. 30, 2021
P069: Hippocrates, the Scientist? Sources for the modern Reception of the Hippocratic treatise On the Sacred Disease
Oct. 16, 2020 - Oct. 15, 2021
J75: Spatio-Temporal Modelling and Forecasting of Infectious Disease Spread Based on Surveillance Data
Oct. 16, 2018 - Oct. 15, 2021
IZKF-J70 (M4): From gene to function: a translational pipeline for gene discovery and allele testing in kidney disease
Oct. 1, 2018 - Sept. 30, 2021
E31: Targeting impaired proteasomal degradation in neurodevelopmental disorders
Jan. 1, 2020 - Aug. 31, 2021
IZKF-N1-GA: Understanding the plasticity of cancer cells
Aug. 1, 2015 - July 31, 2021
J74: The role of CtBP1 in hippocampal and cortical neuroplasticity
Feb. 1, 2019 - July 31, 2021
IZKF-N1 Plasticity of cancer cells: Understanding the plasticity of cancer cells
Aug. 1, 2015 - July 31, 2021
M5-ZKF-J67: Metabolic Reprogramming as a Gatekeeper for Induction/Function of Myeloid Derived Suppressor Cells in AML
Jan. 1, 2018 - June 30, 2021
IZKF-J71 (M4): Inhibition of the purinergic receptor P2Y2R as a potential therapeutic intervention in ADPKD
Jan. 1, 2019 - June 30, 2021
‹
1
...
20
21
22
23
24
...
26
›